Related references
Note: Only part of the references are listed.Perinatal Risk Factors for Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants: A Pregnancy Disorder-Based Approach
Xavier Durrmeyer et al.
JOURNAL OF PEDIATRICS (2012)
Pathogenesis and treatment of bronchopulmonary dysplasia
Jason Gien et al.
CURRENT OPINION IN PEDIATRICS (2011)
Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity
Hilal Ozkan et al.
JOURNAL OF PERINATAL MEDICINE (2011)
Angiogenesis-related gene expression profiling in ventilated preterm human lungs
Monique E. De Paepe et al.
EXPERIMENTAL LUNG RESEARCH (2010)
Neonatal outcomes of premature infants born to preeclamptic mothers
Merih Cetinkaya et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2010)
Maternal Preeclampsia Predicts the Development of Bronchopulmonary Dysplasia
Anne R. Hansen et al.
JOURNAL OF PEDIATRICS (2010)
The management of evolving bronchopulmonary dysplasia
Sven M. Schulzke et al.
PAEDIATRIC RESPIRATORY REVIEWS (2010)
Special Report-Neonatal Resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
John Kattwinkel et al.
PEDIATRICS (2010)
Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer
J. M. Foidart et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
The 'new' bronchopulmonary dysplasia: challenges and commentary
T. Allen Merritt et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2009)
Epidemiology of bronchopulmonary dysplasia
Linda J. Van Marter
SEMINARS IN FETAL & NEONATAL MEDICINE (2009)
Advances in the understanding of eclampsia
S. Ananth Karumanchi et al.
CURRENT HYPERTENSION REPORTS (2008)
Molecular mechanisms of preeclampsia
Walter P. Mutter et al.
MICROVASCULAR RESEARCH (2008)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers
PN Tsao et al.
PEDIATRICS (2005)
Delivery before 32 weeks of gestation for maternal pre-eclampsia: neonatal outcome and 2-year developmental outcome
SW Cheng et al.
EARLY HUMAN DEVELOPMENT (2004)
Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons
WM Maniscalco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn
P Lassus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia
AJ Bhatt et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia
JC Livingston et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Y Kasahara et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infants
O Baud et al.
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2000)
Preterm delivery for maternal or fetal indications:: maternal morbidity, neonatal outcome and late sequelae in infants
M Kurkinen-Räty et al.
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2000)
Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity
K Lashkari et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
